SECURITIES AND EXCHANGE COMMISSION
Washington D.C 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
SPECTRX, INC.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
847635109
(CUSIP Number)
H. Vaughan Blaxter, III
1900 Grant Building
Pittsburgh, Pennsylvania 15219
(412) 281-2620
(Name, address and telephone number of person
authorized to receive notices and communications)
July 7, 1997
Date of Event which Requires Filing of
this Statement
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject of
this statement, and is filing this statement because of Rule
13d-1(b) (3) or (4), check the following: [ ]
Check the following box if a fee is being paid with this
statement: [ ]
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HILLMAN MEDICAL VENTURES 1993 L.P.
I.D. #51-0345071
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
714,286
8 Shared Voting Power
9 Sole Dispositive Power
714,286
10 Shared Dispositve Power
11 Aggregate Amount Beneficially Owned by Each Reporting Person
714,286
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
9.4%
14 Type of Reporting Person
PN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HILLMAN MEDICAL VENTURES 1994 L.P.
I.D. #51-0353407
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
275,953
8 Shared Voting Power
9 Sole Dispositive Power
275,953
10 Shared Dispositve Power
11 Aggregate Amount Beneficially Owned by Each Reporting Person
275,953
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
3.6%
14 Type of Reporting Person
PN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HILLMAN MEDICAL VENTURES 1995 L.P.
I.D. #51-0364601
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
101,860
8 Shared Voting Power
9 Sole Dispositive Power
101,860
10 Shared Dispositve Power
11 Aggregate Amount Beneficially Owned by Each Reporting Person
101,860
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
1.3%
14 Type of Reporting Person
PN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HILLMAN MEDICAL VENTURES 1996 L.P.
I.D. #51-0372016
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
423,102
8 Shared Voting Power
9 Sole Dispositive Power
423,102
10 Shared Dispositve Power
11 Aggregate Amount Beneficially Owned by Each Reporting Person
423,102
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
5.6%
14 Type of Reporting Person
PN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HILLMAN MEDICAL VENTURES 1997 L.P.
I.D. #52-2028335
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
75,000
8 Shared Voting Power
9 Sole Dispositive Power
75,000
10 Shared Dispositve Power
11 Aggregate Amount Beneficially Owned by Each Reporting Person
75,000
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
1.0%
14 Type of Reporting Person
PN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HILLMAN/DOVER LIMITED PARTNERSHIP
I.D. #51-0386294
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
PN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
CASHON BIOMEDICAL ASSOCIATES L.P.
I.D. #23-2555178
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
PN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
WILMINGTON SECURITIES, INC.
I.D. #51-0114700
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
CO
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
WILMINGTON INVESTMENTS, INC.
I.D. #51-0344688
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
CO
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
THE HILLMAN COMPANY
I.D. #25-1011286
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Pennsylvania
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
CO
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HENRY L. HILLMAN, ELSIE HILLIARD HILLMAN & C. G. GREFENSTETTE,
TRUSTEES OF THE HENRY L. HILLMAN TRUST U/A DATED NOVEMBER 18, 1985
I.D. #18-2145466
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Pennsylvania
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
OO
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
C. G. GREFENSTETTE
I.D. ####-##-####
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
U.S.
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
IN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HENRY L. HILLMAN
I.D. ####-##-####
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
U.S.
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
IN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
ELSIE HILLIARD HILLMAN
I.D. ####-##-####
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
U.S.
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
IN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
CHARLES G. HADLEY
I.D. ####-##-####
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
U.S.
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
IN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
HAL S. BRODERSON
I.D. ####-##-####
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
U.S.
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
IN
<PAGE>
CUSIP NO. 847635109
1 Name of Reporting Person S.S. or I.R.S. Identification No. of
above Person
RONALD J. BRENNER
I.D. ####-##-####
2 Check the Appropriate Box if Member of a Group
(a) [ X ] (b) [ ]
3 SEC Use Only
4 Source of Funds
OO
5 Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
U.S.
Number of Shares Beneficially Owned by Each Reporting Person With
7 Sole Voting Power
8 Shared Voting Power
1,590,201
9 Sole Dispositive Power
10 Shared Dispositve Power
1,590,201
11 Aggregate Amount Beneficially Owned by Each Reporting Person
1,590,201
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
13 Percent of Class Represented by Amount in Row (11)
21.0%
14 Type of Reporting Person
IN
<PAGE>
SCHEDULE 13D
This statement ("Statement") constitutes the Schedule 13D
filed with the Securities and Exchange Commission (the
"Commission") on July 17, 1997 (the "Filing").
Item 1. Security and Issuer
This Statement relates to the Common Stock, $0.001 par value, of
SpectRx, Inc., a Delaware corporation (the "Issuer"). The
address of the Issuer's principal executive office is 6025A Unity
Drive, Norcross, Georgia 30071.
Item 2. Identity and Background
(a) Names of persons filing (individually, the "Registrant" and
collectively, the "Registrants"):
Hillman Medical Ventures 1993 L.P., a Delaware limited
partnership, whose general partners are Hillman/Dover
Limited Partnership and Cashon Biomedical Associates L.P.
Hillman Medical Ventures 1994 L.P., a Delaware limited
partnership, whose general partners are Hillman/Dover
Limited Partnership and Cashon Biomedical Associates L.P.
Hillman Medical Ventures 1995 L.P., a Delaware limited
partnership, whose general partners are Hillman/Dover
Limited Partnership and Cashon Biomedical Associates L.P.
Hillman Medical Ventures 1996 L.P., a Delaware limited
partnership, whose general partners are Hillman/Dover
Limited Partnership and Cashon Biomedical Associates L.P.
Hillman Medical Ventures 1997 L.P., a Delaware limited
partnership, whose general partners are Hillman/Dover
Limited Partnership and Cashon Biomedical Associates L.P.
Hillman/Dover Limited Partnership, a Delaware limited
partnership whose general partner is Wilmington Securities,
Inc.
Cashon Biomedical Associates L.P., a Delaware limited
partnership whose general partners are Charles G. Hadley,
Hal S. Broderson and Ronald J. Brenner.
Wilmington Securities, Inc., a wholly-owned subsidiary of
Wilmington Investments, Inc.
Wilmington Investments, Inc., a wholly-owned subsidiary of
The Hillman Company.
The Hillman Company, a corporation controlled by Henry L.
Hillman, Elsie Hilliard Hillman and C. G. Grefenstette,
as Trustees of the Henry L. Hillman Trust U/A dated
November 18, 1985.
Henry L. Hillman, Elsie Hilliard Hillman and C. G.
Grefenstette, Trustees of the Henry L. Hillman Trust U/A
dated November 18, 1985 (the "1985 Trust").
C. G. Grefenstette
Henry L. Hillman
Elsie Hilliard Hillman
Charles G. Hadley
Hal S. Broderson
Ronald J. Brenner
The name, position, business address and citizenship
of each director and executive officer of the entities
listed above, each controlling person of such entities
and each director and executive officer of any person
or corporation in control of said entities, is attached
hereto as Exhibit 1.
(b) Business Address
The addresses of the Registrants are as follows:
The Hillman Company and the 1985 Trust are each located at:
1900 Grant Building
Pittsburgh, Pennsylvania 15219
Wilmington Securities, Inc., Wilmington Investments, Inc.,
Hillman/Dover Limited Partnership, Hillman Medical Ventures
1993 L.P., Hillman Medical Ventures 1994 L.P., Hillman
Medical Ventures 1995 L.P., Hillman Medical Ventures
1996 L.P. and Hillman Medical Ventures 1997 L.P. are
located at:
824 Market Street, Suite 900
Wilmington, Delaware 19801
Cashon Biomedical Associates L.P., Charles G. Hadley,
Hal S. Broderson and Ronald J. Brenner are located at:
One Tower Bridge, Suite 1350
100 Front Street
Conshohocken, Pennsylvania 19428
C. G. Grefenstette
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Henry L. Hillman
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Elsie Hilliard Hillman
2000 Grant Building
Pittsburgh, Pennsylvania 15219
(c) Principal occupation or employment
The principal occupations of the limited partnerships
listed in response to Item 2(a) are: investments in
medical area.
The principal occupations of the corporations, listed in
response to Item 2(a) are: diversified investments and
operations.
The principal occupations of the 1985 Trust is:
diversified investments and operations.
Charles G. Hadley
General Partner, Cashon Biomedical Associates L.P.
Hal S. Broderson
General Partner, Cashon Biomedical Associates L.P.
Ronald J. Brenner
General Partner, Cashon Biomedical Associates L.P.
C. G. Grefenstette
See Exhibit 1
Henry L. Hillman
See Exhibit 1
Elsie Hilliard Hillman
See Exhibit 1
(d) Criminal convictions
None of the persons named in Item 2(a)(including Exhibit
1) have been convicted in a criminal proceeding in the
last five years.
(e) Civil proceedings
None of the persons listed in response to Item 2(a)
(including Exhibit 1) have in the last five years been
subject to a judgment, decree or final order as described
in Item 2, subsection (e) of Schedule 13D.
(f) Citizenship
The 1985 Trust is a Pennsylvania trust.
Wilmington Securities, Inc. and Wilmington Investments, Inc.
are Delaware corporations.
The Hillman Company is a Pennsylvania corporation.
Hillman/Dover Limited Partnership, Cashon Biomedical
Associates L.P., Hillman Medical Ventures 1993 L.P.,
Hillman Medical Ventures 1994 L.P., Hillman Medical
Ventures 1995 L.P., Hillman Medical Ventures 1996 L.P.
and Hillman Medical Ventures 1997 L.P. are Delaware
limited partnerships.
C. G. Grefenstette, Henry L. Hillman, Elsie Hilliard
Hillman, Charles G. Hadley, Hal S. Broderson and
Ronald J. Brenner are U.S. citizens.
Item 3. Source and Amount of Funds or Other Consideration
None.
Item 4. Purpose of Transaction
On July 7, 1997, the Issuer completed a registered public
offering of shares of its Common Stock. In connection with such
offering, (a) Hillman Medical Ventures 1994 L.P. exercised warrants
for 85,714 shares of Series A Preferred Stock for a total exercise
price of $85,714, which shares converted into 61,225 shares of
Common Stock; (b) Hillman Medical Ventures 1995 L.P. and Hillman
Medical Ventures 1996 L.P. exercised warrants for 53,572 shares and
21,009 shares of Common Stock, respectively, for total exercise
prices of $60,000 and $23,529.60; and (c) Hillman Medical Ventures
1997 L.P. purchased 75,000 shares of Common Stock in the public
offering for a price of $7.00 per share.
Except as set forth above, the Registrants have no present
plans or proposals which relate to or would result in (a) the
acquisition by any person of additional securities of the Issuer
or the disposition of securities of the Issuer, (b) an
extraordinary corporate transaction, such as a merger,
reorganization, or liquidation involving the Issuer or any of
its subsidiaries, (c) a sale or transfer of a material amount of
the assets of the Issuer or any of its subsidiaries, (d) any
change in the present Board of Directors or Management of the
Issuer including any plans or proposals to change the number or
term of Directors or to fill any existing vacancies on the
Board, (e) any material change in the present capitalization or
dividend policy of the Issuer, (f) any other material change in
the Issuer's business or corporate structure, (g) changes in the
Issuer's charter, by-laws or instruments corresponding thereto
or other actions which may impede the acquisition of control of
the Issuer by any person, (h) causing a class of securities of
the Issuer to be delisted from a national securities exchange or
to cease to be authorized to be quoted in an inter-dealer
quotation system of a registered national securities
association, (i) a class of equity securities of the Issuer
becoming eligible for termination of registration pursuant to
Section 12(g)(4) of the Act of 1933, or (j) any action similar
to those enumerated above.
Item 5. Interest in Securities of the Issuer
(a) Beneficial Ownership
The following is a list of the Issuer's Common Stock
of which each Registrant is a direct, beneficial owner.
It includes the number of shares held and the percentage
of the class of such shares that are held by such
Registrant.
<TABLE>
<CAPTION>
Name Number of Shares % of Class of Shares
<S> <C> <C>
Hillman Medical
Ventures 1993 L.P. 714,286 9.43%
Hillman Medical
Ventures 1994 L.P. 275,953 3.64%
Hillman Medical
Ventures 1995 L.P. 101,860 1.34%
Hillman Medical
Ventures 1996 L.P. 423,102 5.59%
Hillman Medical
Ventures 1997 L.P. 75,000 .99%
</TABLE>
(b) Power to Vote or Dispose of Shares
Each person listed above in response to Item 5(a)
has the sole power to vote and to direct the vote
and the sole power to dispose of and direct the
disposition of those shares except as follows:
(i) Wilmington Securities, Inc., Wilmington Investments,
Inc., The Hillman Company, Henry L. Hillman, as
settlor and Trustee of the 1985 Trust, and Elsie
Hilliard Hillman and C. G. Grefenstette, as Trustees
of the 1985 Trust, may be deemed to share voting
and disposition power regarding 1,590,201 shares of
Common Stock held beneficially by Hillman Medical
Ventures 1993 L.P., Hillman Medical Ventures 1994
L.P., Hillman Medical Ventures 1995 L.P., Hillman
Medical Ventures 1996 L.P. and Hillman Medical
Ventures 1997 L.P., whose general partners are
Hillman/Dover Limited Partnership and Cashon
Biomedical Associates L.P. Wilmington Securities,
Inc. is the general partner of Hillman/Dover
Limited Partnership.
(ii) As trustees of the 1985 Trust, Henry L. Hillman, Elsie
Hilliard Hillman and C. G. Grefenstette may be deemed
to own beneficially and share voting and disposition
power over 1,590,201 shares of Common Stock.
(iii) Cashon Biomedical Associates L.P., Charles G. Hadley,
Hal S. Broderson and Ronald J. Brenner may be deemed
to own benefically and share voting and disposition
power over 1,590,201 shares of Common Stock.
(c), (d) and (e). Not applicable.
Item 6. Contracts, Arrangements, Understandings of Relationships
With Respect to Securities of the Issuer
None.
Item 7. Material to be Filed as Exhibits
Exhibit 1. Information concerning officers and directors of
reporting persons and certain affiliates thereof.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
HILLMAN MEDICAL VENTURES 1993 L.P.,
HILLMAN MEDICAL VENTURES 1994 L.P.,
HILLMAN MEDICAL VENTURES 1995 L.P.,
HILLMAN MEDICAL VENTURES 1996 L.P.,
and HILLMAN MEDICAL VENTURES 1997 L.P.
By Hillman/Dover Limited Partnership,
a General Partner
By Wilmington Securites, Inc., the sole
General Partner
By /s/ Darlene Clarke
----------------------------------------
Darlene Clarke, Vice President
By Cashon Biomedical Associates L.P.,
a General Partner
By /s/ Charles G. Hadley
----------------------------------------
Charles G. Hadley, General Partner
By /s/ Hal S. Broderson
----------------------------------------
Hal S. Broderson, General Partner
By /s/ Ronald J. Brenner
----------------------------------------
Ronald J. Brenner, General Partner
HILLMAN/DOVER LIMITED PARTNERSHIP
By Wilmington Securities, Inc.,
the sole General Partner
By /s/ Darlene Clarke
---------------------------------------
Darlene Clarke, Vice President
CASHON BIOMEDICAL ASSOCIATES L.P.
By /s/ Charles G. Hadley
----------------------------------------
Charles G. Hadley, General Partner
By /s/ Hal S. Broderson
----------------------------------------
Hal S. Broderson, General Partner
By /s/ Ronald J. Brenner
----------------------------------------
Ronald J. Brenner, General Partner
WILMINGTON SECURITIES, INC.
By /s/ Darlene Clarke
----------------------------------------
Darlene Clarke, Vice President
WILMINGTON INVESTMENTS, INC.
By /s/ Darlene Clarke
----------------------------------------
Darlene Clarke, Vice President
THE HILLMAN COMPANY
By /s/ Lawrence M. Wagner
----------------------------------------
Lawrence M. Wagner, President
HENRY L. HILLMAN, ELSIE HILLIARD HILLMAN &
C. G. GREFESNSTETTE, TRUSTEES OF THE HENRY
L. HILLMAN TRUST U/A DATED NOVEMBER 18, 1985
By /s/ C. G. Grefenstette
----------------------------------------
C. G. Grefenstette, Trustee
/s/ C. G. Grefenstette
----------------------------------------
C. G. Grefenstette
/s/ Henry L. Hillman
----------------------------------------
Henry L. Hillman
/s/ Elsie Hilliard Hillman
----------------------------------------
Elsie Hilliard Hillman
/s/ Charles G. Hadley
----------------------------------------
Charles G. Hadley
/s/ Hal S. Broderson
----------------------------------------
Hal S. Broderson
/s/ Ronald J. Brenner
----------------------------------------
Ronald J. Brenner
EXHIBIT 1
<TABLE>
<CAPTION>
PRINCIPAL OFFICERS AND DIRECTORS OF
THE HILLMAN COMPANY, ALL OF WHOM ARE U.S. CITIZENS
Name and Address Title
<S> <C>
Henry L. Hillman Chairman of the Executive Committee
2000 Grant Building and Director
Pittsburgh, Pennsylvania 15219
C. G. Grefenstette Chairman of the Board and
2000 Grant Building Director
Pittsburgh, Pennsylvania 15219
Lawrence M. Wagner President, Chief Executive Officer
2000 Grant Building and Director
Pittsburgh, Pennsylvania 15219
H. Vaughan Blaxter, III Vice President, Secretary, General
1900 Grant Building Counsel and Director
Pittsburgh, Pennsylvania 15219
Mark J. Laskow Vice President and Director
1900 Grant Building
Pittsburgh, Pennsylvania 15219
Anthony J. Burlando Vice President - Risk Management
1900 Grant Building
Pittsburgh, Pennsylvania 15219
James R. Philp Vice President - Personnel and
2000 Grant Building Administration
Pittsburgh, Pennsylvania 15219
Richard M. Johnston Vice President - Investments and
2000 Grant Building Director
Pittsburgh, Pennsylvania 15219
John W. Hall Vice President - Accounting and
1800 Grant Building Information Services
Pittsburgh, Pennsylvania 15219
Timothy O. Fisher Vice President
1900 Grant Building
Pittsburgh, Pennsylvania 15219
Bruce I. Crocker Vice President
1800 Grant Building
Pittsburgh, Pennsylvania 15219
Denis P. McCarthy Vice President
1900 Grant Building
Pittsburgh, Pennsylvania 15219
Charles H. Bracken, Jr. Treasurer
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Bartley J. Rabuha Controller - Real Estate
1800 Grant Building
Pittsburgh, Pennsylvania 15219
Jeffrey A. Davis Assistant Treasurer
2000 Grant Building
Pittsburgh, Pennsylvania 15219
D. Richard Roesch Assistant Treasurer
1800 Grant Building
Pittsburgh, Pennsylvania 15219
Michael S. Adamcyk Assistant Secretary and
2000 Grant Building Assistant Treasurer
Pittsburgh, Pennsylvania 15219
Mary Black Strong Assistant Treasurer
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Carol J. Cusick Riley Vice President, Associate General
1900 Grant Building Counsel and Assistant Secretary
Pittsburgh, Pennsylvania 15219
Cornel Conley Controller - Corporate
1800 Grant Building
Pittsburgh, Pennsylvania 15219
Mark M. Poljak Controller - Taxes
1800 Grant Building
Pittsburgh, Pennsylvania 15219
Elsie H. Hillman Director
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Juliet Lea Hillman Simonds Director
2000 Grant Building
Pittsburgh, Pennsylvania 15219
PRINCIPAL OFFICERS AND DIRECTORS OF
WILMINGTON INVESTMENTS, INC., ALL OF WHOM ARE U.S. CITIZENS
Lawrence M. Wagner President
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Darlene Clarke Vice President, Chief Financial
824 Market Street, Suite 900 Officer, Treasurer and Director
Wilmington, Delaware 19801
Lario M. Marini Senior Vice President and Director
Wilmington Trust Center
Wilmington, Delaware 19801
Richard H. Brown Assistant Vice President and
824 Market Street, Suite 900 Assistant Secretary
Wilmington, Delaware 19801
H. Vaughan Blaxter, III Secretary
1900 Grant Building
Pittsburgh, Pennsylvania 15219
Charles H. Backen, Jr. Assistant Secretary and
2000 Grant Building Assistant Treasurer
Pittsburgh, Pennsylvania 15219
Jody B. Cosner Assistant Secretary
824 Market Street, Suite 900
Wilmington, Delaware 19801
Joan E. Bachner Assistant Treasurer
824 Market Street, Suite 900
Wilmington, Delaware 19801
Russell W. Ayres, III Director
1900 Grant Building
Pittsburgh, Pennsylvania 15219
PRINCIPAL OFFICERS AND DIRECTORS OF
WILMINGTON SECURITIES, INC., ALL OF WHOM ARE U.S. CITIZENS
Lawrence M. Wagner President
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Darlene Clarke Vice President, Chief Financial
824 Market Street, Suite 900 Officer, Treasurer and Director
Wilmington, Delaware 19801
Lario M. Marini Senior Vice President and Director
Wilmington Trust Center
Wilmington, Delaware 19801
Richard H. Brown Assistant Vice President and
824 Market Street, Suite 900 Assistant Secretary
Wilmington, Delaware 19801
Marian F. Dietrich Secretary
1900 Grant Building
Pittsburgh, Pennsylvania 15219
Charles H. Bracken, Jr. Assistant Secretary and
2000 Grant Building Assistant Treasurer
Pittsburgh, Pennsylvania 15219
Jody B. Cosner Assistant Secretary
824 Market Street, Suite 900
Wilmington, Delaware 19801
Joan E. Bachner Assistant Treasurer
824 Market Street, Suite 900
Wilmington, Delaware 19801
Russell W. Ayres, III Director
1900 Grant Building
Pittsburgh, Pennsylvania 15219
GENERAL PARTNERS OF: HILLMAN MEDICAL VENTURES 1993 L.P.,
HILLMAN MEDICAL VENTURES 1994 L.P., HILLMAN MEDICAL VENTURES
1995 L.P., HILLMAN MEDICAL VENTURES 1996 L.P., and HILLMAN
MEDICAL VENTURES 1997 L.P., BOTH OF WHICH WERE ORGANIZED
IN THE U.S.
Hillman/Dover Limited Partnership
824 Market Street, Suite 900
Wilmington, Delaware 19801
Cashon Biomedical Associates L.P.
One Tower Bridge, Suite 1350
100 Front Street
Conshohocken, Pennsylvania 19428
GENERAL PARTNER OF HILLMAN/DOVER LIMITED PARTNERSHIP, WHICH
WAS ORGANIZED IN THE U.S.
Wilmington Securities, Inc.
824 Market Street, Suite 900
Wilmington, Delaware 19801
GENERAL PARTNERS OF CASHON BIOMEDICAL ASSOCIATES L.P.,
ALL OF WHOM ARE U.S. CITIZENS
Charles G. Hadley
One Tower Bridge, Suite 1350
100 Front Street
Conshohocken, Pennsylvania 19428
Hal S. Broderson
One Tower Bridge, Suite 1350
100 Front Street
Conshohocken, Pennsylvania 19428
Ronald J. Brenner
One Tower Bridge, Suite 1350
100 Front Street
Conshohocken, Pennsylvania 19428
TRUSTEES OF THE HENRY L. HILLMAN TRUST U/A TRUST
DATED NOVEMBER 18, 1985, ALL OF WHOM ARE U.S. CITIZENS
Henry L. Hillman
2000 Grant Building
Pittsburgh, Pennsylvania 15219
Elsie Hilliard Hillman
2000 Grant Building
Pittsburgh, Pennsylvania 15219
C. G. Grefenstette
2000 Grant Building
Pittsburgh, Pennsylvania 15219
</TABLE>
